The New York Times reports that Chinese vaccines have been administered to 60,000 people in clinical trials, many of them around the world, and none of them have experienced any serious adverse reactions, according to a senior Chinese official.
The figures came from Tian Baoguo, a senior official at China’s Ministry of Science and Technology, who spoke at a news conference. “Initial results show that they are safe,” he said.
China has four vaccine candidates in Phase 3 trials, the last stage of testing before regulatory approval. Because the outbreak is largely under control in China, these trials are conducted in more than 10 countries.
Within China, the Chinese government has not waited for clinical trials to conclude before vaccinating tens of thousands of people. Officials have already laid out plans to give shots to even more people, citing emergency use. But scientists have warned that taking a vaccine that has not completed Phase 3 trials carries health risks. On Sunday, the eastern Chinese city of Yiwu stopped the sale of a coronavirus vaccine after dozens of people demanded to be inoculated over the weekend.
Read more via The New York Times